Teladoc Health vs Humata Health

Side-by-side comparison of AI visibility scores, market position, and capabilities

Teladoc Health leads in AI visibility (82 vs 35)
Teladoc Health logo

Teladoc Health

LeaderHealthcare

Telehealth

$2.56B revenue 2024; Q2 2025 $631.9M (-1.6% YoY); 101-103M projected US members 2025; telehealth market leader; telehealth market $123.26B 2024 to $455.27B 2030; 46.58% North America share

AI VisibilityBeta
Overall Score
A82
Category Rank
#14 of 596
AI Consensus
93%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
79
Gemini
81

About

Teladoc Health is the world's largest telehealth company, founded in 2002 and headquartered in Purchase, New York, that pioneered on-demand virtual healthcare delivery in the United States. The company was founded on the premise that patients should be able to access physicians anytime and anywhere without traveling to a physical office — a model that took over a decade to gain mainstream acceptance before becoming a necessity during the COVID-19 pandemic. Teladoc's mission is to provide whole-person virtual care that addresses physical health, mental health, and chronic condition management through an integrated digital platform.\n\nTeladoc's platform encompasses general medical, dermatology, nutrition, and specialty care through its core telehealth offering; mental health and therapy through BetterHelp, the world's largest online therapy platform; virtual primary care and chronic condition management through Teladoc Primary360; and complex care navigation through its integrated whole-person health approach. The company serves employers, health plans, hospitals, and health systems, delivering virtual care to members across the US and internationally. BetterHelp has become a significant consumer-facing revenue driver, connecting individuals directly with licensed therapists without employer or insurance intermediaries.\n\nTeladoc reported $2.56 billion in revenue for 2024 and projects 101 to 103 million US members in 2025. The company trades on the NYSE under TDOC and holds a substantial lead in telehealth market share through its scale, multi-specialty breadth, and direct-to-consumer mental health reach via BetterHelp. Despite post-pandemic normalization and the $13.7 billion Livongo write-down in 2022, Teladoc remains the largest and most diversified virtual care platform, with continued investment in AI-powered clinical decision support and chronic disease management to drive the next phase of growth.

Full profile
Humata Health logo

Humata Health

EmergingDigital Health

Prior Authorization AI (Provider Side)

Raised $25M (Blue Venture Fund, Optum Ventures, Highmark Ventures). 225+ hospitals. ML recommends which clinical documents to include in prior auth submissions, reducing denials before submission.

AI VisibilityBeta
Overall Score
D35
Category Rank
#538 of 596
AI Consensus
84%
Trend
stable
Per Platform
ChatGPT
36
Perplexity
36
Gemini
40

About

Humata Health is a prior authorization AI platform serving the provider side of healthcare — helping hospital systems optimize their prior authorization submissions to reduce denial rates before claims are ever sent to payers. The company has raised $25 million from Blue Venture Fund, Optum Ventures, and Highmark Ventures, and is deployed at 225+ hospitals. Founded by an MD, the platform applies ML to recommend the specific clinical documentation that each payer's prior authorization algorithm weights most heavily.

Full profile

AI Visibility Head-to-Head

82
Overall Score
35
#14
Category Rank
#538
93
AI Consensus
84
stable
Trend
stable
78
ChatGPT
36
79
Perplexity
36
81
Gemini
40
79
Claude
40
79
Grok
34

Key Details

Category
Telehealth
Prior Authorization AI (Provider Side)
Tier
Leader
Emerging
Entity Type
company
brand

Capabilities & Ecosystem

Capabilities

Only Teladoc Health
Telehealth
Only Humata Health
Prior Authorization AI (Provider Side)
Teladoc Health is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.